-
Nafoxidine (INNTooltip
International Nonproprietary Name;
developmental code
names U-11,000A) or
nafoxidine hydrochloride (USANTooltip
United States Adopted...
- SERM,
nafoxidine, was a
clinical candidate for the
treatment of
breast cancer but had side
effects including severe phototoxicity.
Nafoxidine has all...
- (pyrrolidino-4-iodotamoxifen),
levormeloxifene ((L)-ormeloxifene), miproxifene,
nafoxidine,
nitromifene (CI-628), NNC 45-0095, panomifene,
pipendoxifene (ERA-923)...
-
related structurally to
other triphenylethylenes, such as clomifene,
nafoxidine, ospemifene, toremifene, and
numerous others.
Other SERMs, like raloxifene...
- (INN)
nafiverine (INN)
naflocort (INN)
nafomine (INN)
nafoxadol (INN)
nafoxidine (INN)
naftalofos (INN)
naftazone (INN)
naftidrofuryl (INN)
naftifine (INN)...
- etacstil, fispemifene, idoxifene, miproxifene,
miproxifene phosphate,
nafoxidine, ospemifene, panomifene, and toremifene. The
antiestrogen ethamoxytriphetol...
-
antiestrogenic activity. The drug was
described in 1966.
Along with tamoxifen,
nafoxidine, and clomifene, it was one of the
earliest SERMs.
Nitromifene has been...
- LN-1643 LN-2299 LY-117018
Menerba Miproxifene Miproxifene phosphate MRL-37
Nafoxidine Nitromifene NNC 45-0095 NNC 45-0320 NNC 45-0781 NNC 45-1506 Ormeloxifene...
- LN-1643 LN-2299 LY-117018
Menerba Miproxifene Miproxifene phosphate MRL-37
Nafoxidine Nitromifene NNC 45-0095 NNC 45-0320 NNC 45-0781 NNC 45-1506 Ormeloxifene...
- LN-1643 LN-2299 LY-117018
Menerba Miproxifene Miproxifene phosphate MRL-37
Nafoxidine Nitromifene NNC 45-0095 NNC 45-0320 NNC 45-0781 NNC 45-1506 Ormeloxifene...
